Table 1.
Patient and tumor characteristics.
| Series 1 CRC (RMH) |
Series 2 CRC ( SJGSH ) |
||||
|---|---|---|---|---|---|
| No relapse | Relapse | No relapse | Relapse | ||
| Mismatch Repair Status | Proficient | Proficient | Proficient | Proficient | |
| Adjuvant therapy | 6/10 | 6/10 | 0/9 | 6/11 | |
| Average time to relapse | N/A (75+) | 24.6 mo | N/A | 12.0 mo | |
| Median time to relapse | N/A | 18 0 mo | N/A | 11.5 mo | |
| CD8+ Average density (Metamorph area) | 16.2 | 6.2 p = 0.02 | 37.2 | 15.9 p = 0.02 | |
| CD45RO+ Average density (Metamorph area) | 36.5 | 24.4 p = NS | 49.5 | 36.7 p = NS | |
| |
Combined Series |
|
|
|
|
| Location (Total) | No Relapse | Relapse | |||
| Right-side (17) | 9 | 8 | |||
| Left-side (23) | 10 | 13 | |||
All patients had Stage B CRC.